Brind.

Entities / Company

Blueprint Medicines (United States).

company in Cambridge, United States

Seen in 13 reportsLast reported May 20

Reports this week: 0
Active events: 0
Connections: 24

What's happening

Gone quiet

No new reports in 90+ days

The FDA approved AYVAKIT from Blueprint Medicines for the treatment of advanced Systemic Mastocytosis and ISM, targeting the KIT D816V mutation.

Speculative1 report

Connections

The 1 strongest of 24, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.

Sanofi Structural

Sanofi acquired Blueprint Medicines, establishing a parent-subsidiary relationship.

SpeculativeJul 17

Blueprint Medicines (United States) → Sanofi
Sanofi → Blueprint Medicines (United States)

History

Events by the month they began

June 2026

1 event

Jun 8, 2026The FDA approved AYVAKIT from Blueprint Medicines for the treatment of advanced Systemic Mastocytosis and ISM, targeting the KIT D816V mutation.